Status:
UNKNOWN
Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.
Lead Sponsor:
Groupe Hospitalier Diaconesses Croix Saint-Simon
Conditions:
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prosthetic joint infection (PJI) management is complex and requires prosthesis replacement when symptoms duration is greater than 30 days or debridement with modular set replacement when symptoms dura...
Detailed Description
Main objective: Quality of life assessment of patients undergoing prolonged suppressive antibiotherapy for PJI. Secondary objectives: 1. Depressive symptoms assessment in patients undergoing prolon...
Eligibility Criteria
Inclusion
- Patient aged over 18 years old with hip or knee prosthetic infection who consented to participate in the study
- Non-eligible patient to surgical treatment
- Patient eligible to prolonged suppressive antibiotherapy
Exclusion
- patient who does not meet eligibility criteria
- Patient living or traveling abroad for whom 2 years minimum follow up is impossible.
- Patient lawfully deprived of his liberty
- Patient not insured under social security scheme
Key Trial Info
Start Date :
November 9 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02805803
Start Date
November 9 2016
End Date
June 30 2025
Last Update
September 21 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Diaconesses Croix saint Simon
Paris, France, 75020
2
Groupe Hospitalier Dianconesses croix saint Simon
Paris, Île-de-France Region, France, 75020